Cullen Capital Management, LLC Ani Pharmaceuticals Inc Transaction History

Cullen Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$50.28 - $64.61 $317,920 - $408,529	-6,323 Reduced 50.84%	6,113 $354,000
Q2 2023 Aug 14, 2023	BUY	$37.29 - $53.83 $83,193 - $120,094	2,231 Added 21.86%	12,436 $669,000
Q1 2023 May 15, 2023	BUY	$37.61 - $45.72 $383,810 - $466,572	10,205 New	10,205 $405,000
Q3 2022 Nov 10, 2022	BUY	$29.83 - $38.01 $92,055 - $117,298	3,086 Added 29.05%	13,709 $441,000
Q2 2022 Aug 11, 2022	BUY	$23.09 - $33.46 $245,285 - $355,445	10,623 New	10,623 $315,000

212

18.8M

11.7K

10.5K

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $973M
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

Get notified when there are updates to the investment portfolio of Cullen Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Cullen Capital Management, LLC with notifications on news.